USPTO 2015–2025 USPTO PatentsView US Corporation

SpringWorks Therapeutics, Inc.

USPTO PatentsView assignee record - 41 granted patents across 6 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Springworks ranks #7,933 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 6 technology areas.

#7,933
of 49,997 US assignees by volume
Top 10%
by Innovation Score (52.9/100)
18.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7933 · US Corporation #7,933 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 41 grants
  • UPPER-Q #7,933/49,997
  • PHOTO-FINISH Salix Pharmaceuticals
  • CPC-NARROW A61K · 6 areas
  • INNOV-PAR 52.9/100
  • CLAIMS-RICH 18.8 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Salix Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Springworks’s 52.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Springworks

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Springworks's Innovation Score is 52.9/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Springworks?

Each dot is one of Springworks’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Springworks’s own 18.8 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Springworks vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 40.941.041.04141.041.041.1 510152025 Granted patents (volume) Avg claims / patent Salix Pharmaceuticals, Inc. - 41, 14.37Salix Pharmaceuti…SecurityScorecard, Inc. - 41, 18.24SecurityscorecardShenzhen Newsonic Technologies Co., Ltd. - 41, 16.12Shenzhen NewsonicSodastream Industries Ltd. - 41, 5.78Sodastream Indust…Synapse Wireless, Inc. - 41, 17.12Synapse WirelessSynchronoss Technologies, Inc - 41, 17.83SynchronossTata Steel Ijmuiden B.V. - 41, 21.2Tata Steel Ijmuid…TEH YOR Co., Ltd. - 41, 16.12TEH YORSpringWorks Therapeutics, Inc. - 41, 18.8Springworks Thera…
Springworks vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Springworks's grants concentrate

SpringWorks Therapeutics, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 90.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (17 grants) versus a trough of 1 in 2021. By volume, Springworks sits between Salix Pharmaceuticals, Inc. and TEH YOR Co., Ltd..

Springworks's three-year grant acceleration

SpringWorks Therapeutics, Inc. shows 27 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at SpringWorks's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows SpringWorks holds 41 patents at rank #7,935, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near SpringWorks

By rank, the assignees closest to #7,935 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in SpringWorks's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for SpringWorks, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), SpringWorks ranks #584 of 7,163 assignees by patent count in that subclass.

Springworks's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20212022202320242025 13
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
SpringWorks Therapeutics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 2.4%
2022 1 2.4%
2023 9 22.0%
2024 17 41.5%
2025partial year 13 31.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

SpringWorks Therapeutics, Inc.'s patent record in context - here's where to go next.

  • SpringWorks Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 90.2% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #7,933 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare SpringWorks Therapeutics, Inc. against Salix Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.